Plerixafor
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Plerixafor is a prescription drug that helps mobilize hematopoietic stem cells in the blood, aiding their collection for transplantation in patients with certain cancers or blood disorders. It's given as a subcutaneous injection, with each dose containing 24 mg in 1.2 mL. Manufactured by Novadoz Pharmaceuticals LLC. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Plerixafor
Access the FDA dataset for Plerixafor β ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025